It was reported that downregulated RBP1 was associated with the occurrence of prostate cancer, endometrial cancer, and ovarian cancer, etc., while upregulated RBP1 was correlated with the occurrence of lung adenocarcinoma and laryngeal cancer, etc [12–15]. Here, RBP1 is linked to prostate carcinoma.